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SUMMARY
The aim of this study was to perform a retrospective analysis of cases of candidemia in a Brazilian hospital in the city of
Fortaleza, Ceará. A total of 50 blood cultures were analyzed from 40 candidemic patients. The mycological diagnosis was based
on the phenotypical analysis and the patients’ data were recorded in appropriate files. The most frequent species were Candida
parapsilosis (n = 18), followed by C. albicans (n = 14), C. tropicalis (n = 8), C. guillermondii (n = 6), C. glabrata (n = 2), and
Candida spp. (n = 2). A detailed descriptive study was undertaken with 21 patients whose medical records were complete. The
candidemia episodes occurred in eight male patients and 13 female patients. The most representative risk factors implicated in
candidemia were prior antibiotic therapy, central venous catheters, parenteral nutrition, gastric probes and mechanical ventilation.
Death occurred in 13 of the 21-candidemic patients. This study demonstrated the emergence of candidemia caused by C. parapsilosis
in a Brazilian hospital in the city of Fortaleza, Ceará.
KEYWORDS: Candidemia; Candida species; Epidemiology; C. parapsilosis.
INTRODUCTION
Candidemia is defined as a clinical illness associated with the
presence of Candida in patients’ bloodstream22. In recent years, a
progressive increase in the frequency of fungemia has been seen,
particularly among patients receiving antibiotics, immunosuppressive
therapy or parenteral nutrition, as well as among patients exposed to
invasive medical procedures27. Candida is the most important genus
of yeast implicated in human infections, and is associated with almost
80% of all nosocomial fungal infections, representing the major cause
of fungemia1.
Candidemia is the fourth most common cause of hospital blood
infection worldwide23, being associated with extended hospital stays26
and with high mortality rates among critically ill patients14. The
worldwide candidemia rate has increased in many tertiary hospitals
over the past few decades2.
Candida albicans is the main pathogen implicated in candidemia,
being responsible for more than 50% of all Candida bloodstream
infections in the USA, Canada and Europe10,18,21. C. glabrata is the
second leading cause of both blood fungal infections and mucosal
candidiasis in the USA2,14.
Brazilian reports have revealed that C. albicans is the main species
implicated in candidemia4,19 and among the non-albicans species, C.
parapsilosis11 and C. tropicalis7,15 are considered the most important
pathogens. The emergence of non-albicans species as important agents
of candidemia has been linked to a prophylactic or an empiric use of
antifungal drugs26.
The aim of this investigation was to perform a retrospective study
of 21 candidemia cases in a reference hospital in Fortaleza, Ceará
(Northeast Brazil), emphasizing the mycological and epidemiological
aspects.
MATERIAL AND METHODS
This study was performed at a tertiary hospital in the city of
Fortaleza, Ceará, Brazil. The study began by surveying all hemocultures
processed by the hospital’s microbiology laboratory from June 2000
to June 2002. During this period, 4,376 hemocultures were processed
by the Bactec system (Becton Dickinson, Diagnostic Instrument
Systems, Sparkas, MD, USA).
From a total of 4,376 hemocultures examined, 50 yeast-positive
materials were sent to the Medical Mycology Specialized Center at
the Federal University of Ceará, Brazil. The following tests were
conducted for yeast identification: germinative tube, microculture in
Corn-meal agar with Tween 80 (DIFCO, Detroit), CHROMagar-
Candida® (Company, Paris, France) growth, auxonogram, zimogram
subcultures and nitrogen assimilation tests12.
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After the involvement of Candida species had been confirmed by
the laboratory, a through search of each patient’s medical record was
made to collect the following information: age, gender, underlying
condition and antimicrobial prophylaxis (use of therapeutic protocols
with antibiotics and/or antifungals previous to laboratorial confirmation
of sepsis). Invasive procedures, such as dissection of veins, introduction
of catheters and probes, surgery and other possible predisposing factors
were also investigated. This study was conducted with qualitative
analysis of mycological and patient data.
RESULTS
From June 2000 to June 2002, 50 hemocultures from 40 candidemic
patients were analyzed. Candida species were detected in all 50 yeast-
positive hemocultures. The most frequent agent was C. parapsilosis (n
= 18), followed by C. albicans (n = 14), C. tropicalis (n = 8), C.
guillermondiii (n = 6), C. glabrata (n = 2) and Candida spp. (n = 2).
A total of 40 patients medical records were evaluated for candidemia.
However, only 21 patients with available and complete medical records
were included in our research. The analysis of medical records from
these patients revealed that eight were male and 13 were female, age
ranged from 0 to 76 years old, with nine newborn children and 12 adults.
Candidemia episodes occurred mainly in patients from intensive care
units (19 cases); C. parapsilosis was responsible for the fungemia of
seven patients, of which three were premature children. Two patients
were referred from other Medical Care Centers (Table 1).
Of the 21 patients analyzed with positive Candida cultures, 10
presented only candidemia episodes, of which three suffered two
recurrences (Table 1), and 11 showed additional bacteremia episodes.
Of these, four cases of candidemia were prior to bacteria isolation, while
in seven patients, bacteremia episodes preceded Candida isolation.
The most important underlying conditions were gastrointestinal
disease (n = 5), neoplasm (n = 5) and prematurity (n = 6). There were
no differences in risk factors or underlying diseases in candidemia
caused by C. parapsilosis, C. tropicalis, and C. albicans. C. tropicalis
was infrequent among premature children with C. albicans being the
most frequent species among this patient group (Table 1).
From the analysis of 21 patients’ records, it was considered that
the most important coexisting exposures in candidemia development
were prior antibiotic therapy (n = 18), central venous catheters (n =
17), parenteral nutrition (n = 15), gastric probes (n = 17), mechanical
ventilation (n = 15) and surgery (n = 16). Each patient analyzed was
subject to at least one risk factor.
Systemic antifungal drugs were used as prophylactic therapy before
the occurrence of candidemia in only one patient (patient no. 20), with
Table 1
Clinical, epidemiological and laboratorial features of candidemic patients in tertiary care hospital from Northeast Brazil
Patient Age (years)/ Underlying illness Coexisting exposures Species Antifungal therapy Outcome
Sex (days)
1* NB/ F Prematurity B, E,G, K, N, O C. parapsilosis Amphotericin B(1) Died during
treatment
2 NB/ F Prematurity A, B, E, G, K, N, O C. albicans No Died
3 36/ F Complications D, E, G, L, N, O C. tropicalis No Alive
of childbirth
4 63/ F Gastrointestinal disease A, B, C, D, E, F, G, I, N, O C. albicans Fluconazole(16) Died during
treatment
5 28/ F Miscellaneous A, B, D, E, I, K, L, M, N, O C. guillermondii No Alive
conditions
6 NB/ M Prematurity A, B, D, E, G, K, N, O C. albicans Amphotericin B(14) Died during
treatment
7 NB/ F Respiratory disease D, E, G, N, O C. albicans No Died
8 62/ F Circulatory disease B, D, G, K,N, O C. guillermondii No Died
9 24/ F Surgery complications A, B, E, G, K, L, N, O C. tropicalis Fluconazole(9) Alive
10 NB/ F Gastrointestinal disease A, B, D, E, G, F, I, K, N, O C. tropicalis No Died
11 NB/ F Prematurity A, B, E, K, O C. albicans No Died
12 49/ M Neoplasms A, B, C, D, E, F, G, N, O C. glabrata No Alive
13 25/ M Gastrointestinal disease A, B, C, D, E, G, H, N, O C. parapsilosis No Died
14 NB/ F Infectious disease D, E, N, O C. parapsilosis No Died
15* NB/ F Prematurity A, B, C, D, N, O C. parapsilosis No Died
16 76/ M Neoplasms B, C, D, E, G, J, K, N, O C. tropicalis Fluconazole(12) Alive
17* 52/ M Neoplasms A, D, E, I, K C. tropicalis No Alive
18 57/ M Gastrointestinal disease A, B, C, E, K, L C.tropicalis Fluconazole(9) Alive
19 NB/ M Prematurity A, B, G, D, N, O C. albicans Amphotericin B(25) Alive
20 75/ F Neoplasms A, B, C, D, E, F, G, J, L, N, O C. parapsilosis No Died
21 44/ M Gastrointestinal disease A, B, D, G, L, N, O C. albicans Fluconazole(13) Died during
treatment
Patient presented two positive blood cultures at different times; * NB: newborn, A- parenteral nutrition; B- gastric catheter; C- colostomy; D- surgery; E- central venous
access; F- thoracic drain; G- mechanical ventilation; H- peritoneal drain; I- gastrostomy; J- hemodialysis; K- hemotransfusion; L- vesical probe; M- abdominal drain;
N- antibiotic treatment, O- intensive care unit (ICU)
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fluconazole (200 mg per day) for 10 days. Even after candidemia had
been confirmed, only eight patients received antifungal treatment. Three
candidemic patients (patients no. 1, 6, 19) were treated with
amphotericin B (0.5-1 mg/kg/day) for 13 days and the remaining five
patients (patients no. 4, 9, 16, 18, 21) were treated with fluconazole
(150 - 400 mg per day) for an average of 12 days. The remaining 13
patients were not treated with antifungal drugs (Table 1).
Candidemia was responsible for the death of 13 of the 21 patients.
C. albicans was implicated in the death of six of them and C.
parapsilosis was responsible for the death of five patients. Four of
these patients had been treated with antifungal drugs (Table 1).
DISCUSSION
It was found that all the fungal blood infections at the reference
tertiary hospital were caused by yeast of the Candida genus. These
data corroborate some studies in which Candida species were the most
involved in fungemia cases1,15.
In this study, non-albicans species of Candida, were responsible
for a total of 72% of fungemia cases. C. parapsilosis (n = 18) was the
most isolated agent, followed by C. albicans (n = 14), C. tropicalis (n
= 8), C. guillermondiii (n = 6), C. glabrata (n = 2) and Candida spp. (n
= 2). Brazilian reports have revealed that C. albicans is the main agent
of candidemia (20 - 50%), followed by C. parapsilosis (17 - 35%), C.
tropicalis (12 - 27%), and C. guilliermondii (2 - 10%)2.
The increased use of invasive medical procedures as well as the
prophylactic and empirical use of antifungal drugs, especially those of
azolic derivation, has been blamed for the emergence of the non-
albicans species of Candida13,14,20.
C. parapsilosis is widely recognized as a cause of fungemia among
hospitalized patients17. C. parapsilosis is part of the endogenous
microbiota of human beings and is a commensal organism, which
penetrates the blood by rupting the skin. The yeast is capable of forming
biofilm in glucosilated solutions and adhering to plastic materials, such
as catheters used for parenteral nutrition. Over the last few years,
outbreaks and clusters of cross-transmission, total parenteral nutrition
solutions, intravascular devices, and medications have been related to
C. parapsilosis fungemia6,10.
The following were not included in this research: the presence of C.
parapsilosis on the hands of the medical team and on substances which
come into contact with patients, such as catheters and solutions for
intravenous use. However, the information from the literature corroborates
the hypothesis that the medical team could be involved, in some way, in
the contamination of patients, in as much as C. parapsilosis could be
isolated on the hands of healthy professionals9,28. In addition, C. parapsilosis
is an important pathogen of onychomycosis in fingernails4,6,25.
Most of the patients involved in this study (n = 19) were from Intensive
Care Units (ICU); C. parapsilosis were related to candidemia in three
premature children from this unit. However, such episodes occurred on
different dates (case 1: 06/12/2000; case 2: 08/13/2000; case 3: 04/27/
2001). Such high rates of fungal infection in ICUs corroborate the findings
of several authors3,19. These data may be explained by the fact that these
patients are usually considered high risk, depending on life support, thus
subject to multiple invasive procedures which make them more susceptible
to a rapid microbial invasion.
It is important to state that, in addition to the seven strains of C.
parapsilosis isolated from patients with complete medical records
(Table 1), the remaining strains were isolated from patients treated in
the following units: emergency (n = 3), cardiology (n = 2),
gastroenterology (n = 3), intensive care unit (n = 2) and nursing (n =
1). It was observed during this study that the presence of candidemia
cases associated with episodes of bacteremia was considerable (n =
11), especially when the bacteremia preceded candidemia. These data
may be considered a new risk factor, according to ELLIS et al.11, due
to the indiscriminate use of antibiotics in high-risk patients.
The risk factors assessed in our study are also quoted by several
authors7,27. It was seen that prior antibiotic treatment, central venous
access, parenteral nutrition, surgery, mechanical ventilation and gastric
catheterization were all associated with candidemia. From the
therapeutic point of view, it was observed that, of the 21 patients, 13
were not treated with any antifungal agent and of these, four patients
were cured after risk factors had been removed as described above.
Although the literature states an association of risk factors such as
central venous catheter and parenteral nutrition, with C. parapsilosis6,
this was not seen in this study, due to the limited number of samples,
which did not allow statistical analysis.
The species which showed the highest mortality rates were C.
albicans (n = 6) and C. parapsilosis (n = 5). However, HUANG et al.14
reported that C. parapsilosis showed high involvement in cases of
mortality and morbidity, especially in neonates. In our study, cases of
mortality as a result of this agent were observed in untreated patients,
who were diagnosed at a later stage.
This study shows that among all the found yeasts, C. parapsilosis
was the main isolated agent and evidences the importance of C.
parapsilosis in candidemia episodes in a Brazilian tertiary care hospital
in Northeast Brazil.
RESUMO
Candidemia em hospital terciário brasileiro: a importância
da Candida parapsilosis
O presente estudo objetivou desenvolver uma análise retrospectiva
de casos de candidemia em hospital brasileiro na cidade de Fortaleza,
Ceará. Um total de 50 hemoculturas foram analisadas de 40 pacientes
com quadros de candidemia. O diagnóstico micológico foi baseado na
análise morfológica e bioquímica e os dados dos pacientes foram
coletados das histórias clínicas. As espécies mais freqüentes foram
Candida parapsilosis (n = 18), seguida por C. albicans (n = 14), C.
tropicalis (n = 8), C. guillermondii (n = 6), C. glabrata (n = 2) e Candida
spp. (n = 2). Um estudo descritivo foi realizado com apenas 21 pacientes
os quais possuíam dados clínicos completos. Os episódios de
candidemia aconteceram em oito pacientes do sexo masculino e 13 do
feminino. Os fatores de risco implicados em candidemia foram
antibioticoterapia prévia, uso de cateter venoso central, nutrição
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parenteral, sondagem gástrica e ventilação mecânica. A morte aconteceu
em 13 dos 21 pacientes com candidemia. Este estudo demonstrou a
emergência de candidemia causada por C. parapsilosis em um hospital
brasileiro na cidade de Fortaleza, Ceará.
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